Gene · 2052
Papers2,230
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
101 to 120 of 2,230
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Antioxidant Defense Capacity Is Reduced in Thyroid Stem/Precursor Cells Compared to Differentiated Thyrocytes. | Int J Mol Sci | 2023 | 37511265 | PubTator, text mining | PubMed |
| The use of azithromycin and pyrimethamine for treatment of cerebral toxoplasmosis in human immunodeficiency virus-infected patients: a systematic review. | Encephalitis | 2023 | 37469675 | PubTator, text mining | PubMed |
| Electrochemical Rapid Detection of Methamphetamine from Confiscated Samples Using a Graphene-Based Printed Platform. | Sensors (Basel) | 2023 | 37448052 | PubTator, text mining | PubMed |
| Electrochemical Disposable Biosensor to Monitor Dabigatran in Point-of-Care Anticoagulation Therapy. | Molecules | 2023 | 37446615 | PubTator, text mining | PubMed |
| Tissue-Specific Regulation of CFTR Gene Expression. | Int J Mol Sci | 2023 | 37445855 | PubTator, text mining | PubMed |
| Tox21Enricher-Shiny: an R Shiny application for toxicity functional annotation analysis. | Front Toxicol | 2023 | 37441091 | PubTator, text mining | PubMed |
| Order-order assembly transition-driven polyamines detection based on iron-sulfur complexes. | Commun Chem | 2023 | 37420027 | PubTator, text mining | PubMed |
| Does timing of neoadjuvant chemotherapy influence the prognosis in patients with early triple negative breast cancer? | J Cancer Res Clin Oncol | 2023 | 37418056 | PubTator, text mining | PubMed |
| Real-world data of pyrotinib-based therapy for patients with brain metastases of HER2-positive advanced breast cancer: a single-center retrospective analysis and molecular portraits. | Front Oncol | 2023 | 37397372 | PubTator, text mining | PubMed |
| CD25high Effector Regulatory T Cells Hamper Responses to PD-1 Blockade in Triple-Negative Breast Cancer. | Cancer Res | 2023 | 37379438 | PubTator, text mining | PubMed |
| A Multigene Signature Associated with Progression-Free Survival after Treatment for IDH Mutant and 1p/19q Codeleted Oligodendrogliomas. | Cancers (Basel) | 2023 | 37370678 | PubTator, text mining | PubMed |
| Systematic druggable genome-wide Mendelian randomisation identifies therapeutic targets for Alzheimer's disease. | J Neurol Neurosurg Psychiatry | 2023 | 37349091 | PubTator, text mining | PubMed |
| Integrated analyses delineate distinctive immunological pathways and diagnostic signatures for Behcet's disease by leveraging gene microarray data. | Immunol Res | 2023 | 37341899 | PubTator, text mining | PubMed |
| Stability and C-H Bond Activation Reactions of Palladium(I) and Platinum(I) Metalloradicals: Carbon-to-Metal H-Atom Transfer and an Organometallic Radical Rebound Mechanism. | J Am Chem Soc | 2023 | 37318758 | PubTator, text mining | PubMed |
| On the Redox Properties of the Dimers of Thiazol-2-ylidenes That Are Relevant for Radical Catalysis. | ACS Org Inorg Au | 2023 | 37303499 | PubTator, text mining | PubMed |
| Electrochemical Evaluation of Cd, Cu, and Fe in Different Brands of Craft Beers from Quito, Ecuador. | Foods | 2023 | 37297508 | PubTator, text mining | PubMed |
| EPHX1 and GSTP1 polymorphisms are associated with COPD risk: a systematic review and meta-analysis. | Front Genet | 2023 | 37284064 | PubTator, text mining | PubMed |
| Genetic Factors Influencing Warfarin Dose in Han Chinese Population: A Systematic Review and Meta-Analysis of Cohort Studies. | Clin Pharmacokinet | 2023 | 37273173 | PubTator, text mining | PubMed |
| The challenges of classical galactosemia: HRQoL in pediatric and adult patients. | Orphanet J Rare Dis | 2023 | 37268983 | PubTator, text mining | PubMed |
| Exerkines and redox homeostasis. | Redox Biol | 2023 | 37247469 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2052/papers?page=6